Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate-risk Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02271659
What this trial is testing

Medical and Economic Evaluation for Intermediate-risk Prostate Cancer

Who this might be right for
Prostate Cancer
Hospices Civils de Lyon 298
Early research (Phase 1)Active Not RecruitingNCT04147806
What this trial is testing

A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Albert Einstein College of Medicine 31
Large-scale testing (Phase 3)Study completedNCT00304759
What this trial is testing

PROFIT - Prostate Fractionated Irradiation Trial

Who this might be right for
Prostate Cancer
Ontario Clinical Oncology Group (OCOG) 1,204
Testing effectiveness (Phase 2)Study completedNCT00547339
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
University of Texas Southwestern Medical Center 94
Not applicableLooking for participantsNCT03830788
What this trial is testing

Erectile Dysfunction in Good Prognosis Prostate Cancer : Comparison Between Brachytherapy and Stereotactic Body Radiotherapy

Who this might be right for
Prostate Cancer
Center Eugene Marquis 240
Not applicableLooking for participantsNCT04945642
What this trial is testing

High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma

Who this might be right for
Prostate AdenocarcinomaStage IIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage IIC Prostate Cancer AJCC v8+5 more
Jonsson Comprehensive Cancer Center 52
Large-scale testing (Phase 3)WithdrawnNCT03488810
What this trial is testing

Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancer

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Not applicableActive Not RecruitingNCT07674225
What this trial is testing

Dose-dEscalated MR-Guided Radiotherapy for Localized Prostate Cancer

Who this might be right for
Intermediate Risk Prostate Cancer (Diagnosis)Prostate Cancer
Sunnybrook Health Sciences Centre 24
Early research (Phase 1)Ended earlyNCT02875223
What this trial is testing

A Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas

Who this might be right for
Lymphoma, Non-HodgkinNeoplasms
Celgene 75
Post-approval studies (Phase 4)Active Not RecruitingNCT06074510
What this trial is testing

PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer

Who this might be right for
Prostate Cancer
Lantheus Medical Imaging 274
Not applicableLooking for participantsNCT07130682
What this trial is testing

Two-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II Trial

Who this might be right for
Prostate Cancer Patients Treated by Radiotherapy
Hong Kong Sanatorium & Hospital 35
Early research (Phase 1)Active Not RecruitingNCT05917860
What this trial is testing

Neoadjuvant ADT with TULSA in the Treatment of Intermediate Risk Prostate Cancer

Who this might be right for
Localized Prostate CarcinomaCastration-Naive Prostate CancerIntermediate Risk Prostate Cancer+1 more
Turku University Hospital 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT03412396
What this trial is testing

Apalutamide in Treating Patients With Prostate Cancer Before Radical Prostatectomy

Who this might be right for
Prostate AdenocarcinomaStage IIB Prostate Cancer AJCC v8
M.D. Anderson Cancer Center 45
Not applicableUnknownNCT02040610
What this trial is testing

Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Provision Center for Proton Therapy 235
Not applicableActive Not RecruitingNCT01342367
What this trial is testing

Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Chicago 74
Testing effectiveness (Phase 2)UnknownNCT02643511
What this trial is testing

Hemiablative Focal Brachytherapy Pilot Study

Who this might be right for
Prostate Cancer
St George Hospital, Australia 20
Testing effectiveness (Phase 2)Ended earlyNCT02140138
What this trial is testing

An Open Label Randomised Trial of RNActive® Cancer Vaccine in High Risk and Intermediate Risk Patients With Prostate Cancer

Who this might be right for
Prostate Carcinoma
CureVac 35
Not applicableLooking for participantsNCT06518226
What this trial is testing

Two-Fraction Ultrahypofractionated Radiotherapy With Focal Boost for Intermediate Risk, Localized Prostate Cancer

Who this might be right for
Prostate CancerProstate AdenocarcinomaLocalized Prostate Carcinoma
UMC Utrecht 160
Not applicableUnknownNCT02225262
What this trial is testing

A Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate Tumors

Who this might be right for
Prostate CancerCancer of the ProstateProstate Neoplasm
Community Cancer Center, Normal, Illinois 100
Not applicableStudy completedNCT02600156
What this trial is testing

Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors

Who this might be right for
Prostate CancerProstate AdenocarcinomaStage I Prostate Cancer AJCC v8+2 more
Mayo Clinic 7
Next Page